An Act to repeal provisions related to medical marijuana.
Be it enacted by the Legislature of the State of South Dakota:
Section 1. That § 34-20E-2 be AMENDED:
34-20E-2.
The board shall
establish and maintain a prescription drug monitoring program to
monitor the prescribing and dispensing of all controlled substances.
The program
shall
must
utilize a central repository, to which each dispenser shall submit,
by electronic means, information regarding each prescription
dispensed for a controlled substance. The information submitted for
each prescription must include specifically identified data elements
adopted by the board and contained in the 2011 version
of the electronic reporting standard for prescription monitoring
programs, version 4.2 of the American Society for Automation in
Pharmacy.
The
program must include the names of qualifying patients who receive a
registry identification card, as defined in § 34-20G-1,
submitted by the Department of Health
American Society for Automation in Pharmacy Version 4.2 Standard for
Prescription Drug Monitoring Programs.
Section 2. That § 34-20G-1 be REPEALED.
Terms used in this
chapter mean:
(1) "Allowable
amount of cannabis,":
(a) Three ounces of
cannabis or less;
(b) The quantity of
cannabis products as established by rules promulgated by the
department under § 34-20G-72;
(c) If the cardholder has
a registry identification card allowing cultivation, two flowering
cannabis plants and two cannabis plants that are not flowering; and
(d) If the cardholder has
a registry identification card allowing cultivation, the amount of
cannabis and cannabis products that were produced from the
cardholder's allowable plants, if the cannabis and cannabis products
are possessed at the same property where the plants were cultivated;
(2) "Bona fide
practitioner-patient relationship," a treatment or consulting
relationship between a practitioner and patient, during which:
(a) The practitioner
completes, at the initial visit, an assessment of the patient's
medical history and current medical condition, including an
appropriate in-person physical examination;
(b) The patient is under
the practitioner's care for the debilitating medical condition that
qualifies the patient for the medical use of cannabis or has been
referred by the practitioner caring for the patient's debilitating
medical condition that qualifies the patient for the medical use of
cannabis to another practitioner;
(c) The patient has a
reasonable expectation that the practitioner providing the written
certification will continue to provide follow-up care to the patient
to monitor the medical use of cannabis; and
(d) The relationship is
not for the sole purpose of providing a written certification for the
medical use of cannabis unless the patient has been referred by a
practitioner providing care for the debilitating medical condition
that qualifies the patient for the medical use of cannabis;
(3) "Cannabis
products," any concentrated cannabis, cannabis extracts, and
products that are infused with cannabis or an extract thereof, and
are intended for use or consumption by humans. The term includes
edible cannabis products, beverages, topical products, ointments,
oils, and tinctures;
(4) "Cannabis
product manufacturing facility," an entity registered with the
department pursuant to this chapter that acquires, possesses,
manufactures, delivers, transfers, transports, supplies, or sells
cannabis products to a medical cannabis dispensary;
(5) "Cannabis
testing facility" or "testing facility," an
independent entity registered with the department pursuant to this
chapter to analyze the safety and potency of cannabis;
(6) "Cardholder,"
a qualifying patient or a designated caregiver who has been issued
and possesses a valid registry identification card;
(7) "Cultivation
facility," an entity registered with the department pursuant to
this chapter that acquires, possesses, cultivates, delivers,
transfers, transports, supplies, or sells cannabis and related
supplies to a medical cannabis establishment;
(8) "Debilitating
medical condition,":
(a) A chronic or
debilitating disease or medical condition or its treatment that
produces one or more of the following: cachexia or wasting syndrome;
severe, debilitating pain; severe nausea, except nausea associated
with pregnancy; seizures; or severe and persistent muscle spasms;
(b) Acquired immune
deficiency syndrome or positive status for human immunodeficiency
virus;
(c) Amyotrophic lateral
sclerosis;
(d) Multiple sclerosis;
(e) Cancer or its
treatment, if associated with severe or chronic pain, nausea or
severe vomiting, or cachexia or severe wasting;
(f) Crohn's disease;
(g) Epilepsy and
seizures; or
(h) Post-traumatic stress
disorder;
(9) "Department,"
the Department of Health;
(10) "Designated
caregiver," an individual who:
(a) Is at least
twenty-one years of age;
(b) Has agreed to assist
with a qualifying patient's medical use of cannabis;
(c) Has not been
convicted of a disqualifying felony offense; and
(d) Assists no more than
five qualifying patients with the medical use of cannabis, unless the
designated caregiver's qualifying patients each reside in or are
admitted to a health care facility, as defined in § 34-12-1.1,
an accredited prevention or treatment facility, as defined in
§ 34-20A-2,
a mental health center, as defined in § 27A-1-1,
a child welfare agency, as defined in § 26-6-1,
or a community support provider or community services provider, as
defined in § 27B-1-17,
where the designated caregiver is employed;
(11) "Disqualifying
felony offense," a violent crime that was classified as a felony
in the jurisdiction where the person was convicted;
(12) "Edible
cannabis products," any product that:
(a) Contains or is
infused with cannabis or an extract thereof;
(b) Is intended for human
consumption by oral ingestion; and
(c) Is presented in the
form of foodstuffs, beverages, oils, tinctures, or other similar
products;
(13) "Enclosed,
locked facility," any closet, room, greenhouse, building, or
other enclosed area that is equipped with locks or other security
devices that permit access only by a cardholder or a person allowed
to cultivate the plants. Two or more cardholders who reside in the
same dwelling may share one enclosed, locked facility for
cultivation;
(14) "Flowering
cannabis plant," the reproductive state of the cannabis plant in
which the plant shows physical signs of flower budding out of the
nodes of the stem;
(15) "Medical
cannabis" or "cannabis," marijuana as defined in
§ 22-42-1;
(16) "Medical
cannabis dispensary" or "dispensary," an entity
registered with the department pursuant to this chapter that
acquires, possesses, stores, delivers, transfers, transports, sells,
supplies, or dispenses cannabis, cannabis products, paraphernalia, or
related supplies and educational materials to cardholders;
(17) "Medical
cannabis establishment," a cultivation facility, a cannabis
testing facility, a cannabis product manufacturing facility, or a
dispensary;
(18) "Medical
cannabis establishment agent," an owner, officer, board member,
employee, or volunteer at a medical cannabis establishment;
(19) "Medical use,"
includes the acquisition, administration, cultivation, manufacture,
delivery, harvest, possession, preparation, transfer, transportation,
or use of cannabis or paraphernalia relating to the administration of
cannabis to treat or alleviate a registered qualifying patient's
debilitating medical condition or symptom associated with the
patient's debilitating medical condition. The term does not include:
(a) The cultivation of
cannabis by a nonresident cardholder;
(b) The cultivation of
cannabis by a cardholder who is not designated as being allowed to
cultivate on the cardholder's registry identification card; or
(c) The extraction of
resin from cannabis by solvent extraction unless the extraction is
done by a cannabis product manufacturing facility;
(20) "Nonresident
cardholder," a person who:
(a) Has been diagnosed
with a debilitating medical condition, or is the parent, guardian,
conservator, or other person with authority to consent to the medical
treatment of a person who has been diagnosed with a debilitating
medical condition;
(b) Is not a resident of
this state or who has been a resident of this state for fewer than
forty-five days;
(c) Was issued a
currently valid registry identification card or its equivalent by
another state, district, territory, commonwealth, insular possession
of the United States, or country recognized by the United States that
allows the person to use cannabis for medical purposes in the
jurisdiction of issuance; and
(d) Has submitted any
documentation required by the department, and has received
confirmation of registration;
(21) "Practitioner,"
a physician, physician assistant, or advanced practice registered
nurse, who is licensed with authority to prescribe drugs to humans.
In relation to a nonresident cardholder, the term means a person who
is licensed with authority to prescribe drugs to humans in the state
of the patient's residence;
(22) "Qualifying
patient," a person who has been diagnosed by a practitioner as
having a debilitating medical condition;
(23) "Registry
identification card," a document issued by the department that
identifies a person as a registered qualifying patient or registered
designated caregiver, or documentation that is deemed a registry
identification card pursuant to §§ 34-20G-29
to 34-20G-42,
inclusive;
(24) "Safety-sensitive
job," any position with tasks or duties that an employer
reasonably believes could:
(a) Cause the illness,
injury, or death of an individual; or
(b) Result in serious
property damage;
(25) "Under the
influence of cannabis," any abnormal mental or physical
condition that tends to deprive a person of clearness of intellect
and control that the person would otherwise possess, as the result of
consuming any degree of cannabis or cannabis products; and
(26) "Written
certification," a document dated and signed by a practitioner:
(a) Stating that the
patient has a qualifying debilitating medical condition or symptom
associated with the debilitating medical condition;
(b) Affirming that the
document is made in the course of a bona fide practitioner-patient
relationship;
(c) Specifying the
qualifying patient's debilitating medical condition; and
(d) Specifying the
expiration date of the qualifying patient's written certification,
pursuant to § 34-20G-43;
and
(e) Specifying whether
the practitioner has previously issued the patient a written
certification and the date of that written certification.
Section 3. That § 34-20G-2 be REPEALED.
A cardholder is not
subject to arrest, prosecution, or penalty of any kind, or denial of
any right or privilege, including any civil penalty or disciplinary
action by a court or occupational or professional licensing board or
bureau, for:
(l) The medical use of
cannabis in accordance with this chapter, if the cardholder does not
possess more than the allowable amount of cannabis, and if any
cannabis plant is either cultivated in an enclosed, locked facility
or is being transported;
(2) Reimbursement by a
registered qualifying patient to the patient's registered designated
caregiver for direct costs incurred by the registered designated
caregiver for assisting with the registered qualifying patient's
medical use of cannabis;
(3) Transferring the
cannabis to a testing facility;
(4) Compensating a
dispensary or a testing facility for goods or services provided;
(5) Selling,
transferring, or delivering cannabis seeds produced by the cardholder
to a cultivation facility or dispensary; or
(6) Offering or providing
cannabis to a cardholder for a registered qualifying patient's
medical use, to a nonresident cardholder, or to a dispensary if
nothing of value is transferred in return and the person giving the
cannabis does not knowingly cause the recipient to possess more than
the allowable amount of cannabis.
Section 4. That § 34-20G-3 be REPEALED.
No nonresident cardholder
is subject to arrest, prosecution, or penalty in any manner, or
denied any right or privilege, including civil penalty or
disciplinary action by a business or occupational or professional
licensing board or entity, for transporting, purchasing, possessing,
or using medical cannabis in accordance with this chapter if the
nonresident cardholder does not possess more than three ounces of
cannabis and the quantity of cannabis products established by rules
promulgated by the department under § 34-20G-72.
Section 5. That § 34-20G-4 be REPEALED.
There is a presumption
that a qualifying patient or designated caregiver is engaged in the
medical use of cannabis in accordance with this chapter if the
cardholder is in possession of a registry identification card and an
amount of cannabis that does not exceed the allowable amount of
cannabis. The presumption may be rebutted by evidence that conduct
related to cannabis was not for the purpose of treating or
alleviating a qualifying patient's debilitating medical condition or
symptom associated with the qualifying patient's debilitating medical
condition under this chapter.
Section 6. That § 34-20G-5 be REPEALED.
No practitioner is
subject to arrest, prosecution, or penalty of any kind, or denied any
right or privilege, including civil penalty or disciplinary action by
the South Dakota Board of Medical and Osteopathic Examiners or by any
other occupational or professional licensing board or bureau, solely
for providing written certifications or for otherwise stating that,
in the practitioner's professional opinion, a patient is likely to
receive therapeutic or palliative benefit from the medical use of
cannabis to treat or alleviate the patient's serious or debilitating
medical condition or symptoms associated with the serious or
debilitating medical condition. Nothing in this chapter prevents a
practitioner from being sanctioned for:
(1) Issuing a written
certification to a patient with whom the practitioner does not have a
bona fide practitioner-patient relationship; or
(2) Failing to properly
evaluate a patient's medical condition.
Section 7. That § 34-20G-5.1 be REPEALED.
Nothing in this chapter
authorizes a practitioner to provide a written certification to a
patient who is pregnant or breastfeeding.
Section 8. That § 34-20G-5.2 be REPEALED.
If a practitioner issues
a written certification under this chapter, and if the practitioner
is neither the patient's primary care provider nor a specialty
provider caring for the patient's debilitating medical condition, the
practitioner shall, upon issuing the certification, provide
electronic notification of the issuance:
(1) To the patient's
primary care provider; or
(2) To the referring
practitioner, if that individual is caring for the patient's
debilitating medical condition.
The patient's primary
care provider or the referring practitioner shall include any
notification received in accordance with this section in the
patient's medical file.
Section 9. That § 34-20G-6 be REPEALED.
No person licensed by the
state or any other governmental entity to engage in any profession,
occupation, or other activity is subject to disciplinary action,
denial of the rights and privileges of such license, or otherwise
penalized by the licensing authority for lawfully engaging in any
activity authorized under this chapter or providing any service to a
person engaged in activity that is authorized by this chapter merely
because that activity is prohibited by federal law.
Section 10. That § 34-20G-7 be REPEALED.
No person is subject to
arrest, prosecution, or penalty of any kind, or may be denied any
right or privilege, including any civil penalty or disciplinary
action by a court or occupational or professional licensing board or
bureau, for:
(1) Providing or selling
cannabis paraphernalia to a cardholder, nonresident cardholder, or to
a medical cannabis establishment;
(2) Being in the presence
or vicinity of the medical use of cannabis that is exempt from
criminal or civil penalty by this chapter;
(3) Allowing the person's
property to be used for an activity that is exempt from criminal or
civil penalty by this chapter; or
(4) Assisting a
registered qualifying patient with the act of using or administering
cannabis.
Section 11. That § 34-20G-12 be REPEALED.
A cardholder, nonresident
cardholder, or the equivalent of a medical cannabis establishment
that is registered in another jurisdiction may sell or donate
cannabis seeds to a cultivation facility in this state.
Section 12. That § 34-20G-13 be REPEALED.
Any cannabis, cannabis
product, cannabis paraphernalia, or other interest in or right to
property that is possessed, owned, or used in connection with the
medical use of cannabis as allowed under this chapter, or acts
incidental to such use, may not be seized or forfeited. This chapter
does not prevent the seizure or forfeiture of cannabis exceeding the
amount allowed under this chapter, or prevent seizure or forfeiture
if the basis for the action is unrelated to the cannabis that is
possessed, manufactured, transferred, or used in accordance with this
chapter.
Section 13. That § 34-20G-14 be REPEALED.
Possession of, or
application for, a registry identification card does not constitute
probable cause or reasonable suspicion, nor may it be used to support
a search of the person or property of the person possessing or
applying for the registry identification card, or otherwise subject
the person or property of the person to inspection by any
governmental agency.
Section 14. That § 34-20G-15 be REPEALED.
For the purposes of state
law, an activity related to medical cannabis is lawful as long as it
is conducted in accordance with this chapter.
Section 15. That § 34-20G-17 be REPEALED.
No contract entered into
by a cardholder, a medical cannabis establishment, or medical
cannabis establishment agent, or by a person who allows property to
be used for an activity that is exempt from state criminal penalties
by this chapter is unenforceable on the basis that activity related
to cannabis is prohibited by federal law.
Section 16. That § 34-20G-18 be REPEALED.
This chapter does not
authorize any person to engage in, and does not prevent the
imposition of any civil, criminal, or other penalty for engaging in,
the following conduct:
(1) Undertaking any task
under the influence of cannabis, when doing so would constitute
negligence or professional malpractice;
(2) Possessing cannabis
or otherwise engaging in the medical use of cannabis in any
correctional facility;
(3) Smoking or vaping
cannabis:
(a) On any form of public
transportation;
(b) In any public place
or any place that is open to the public; or
(c) If under the age of
twenty-one;
(4) Operating,
navigating, or being in actual physical control of any motor vehicle,
aircraft, train, or motorboat while under the influence of cannabis;
or
(5) Performing any
safety-sensitive job under the influence of cannabis.
Section 17. That § 34-20G-19 be REPEALED.
A cardholder may not be
refused enrollment by a school or a lease by a landlord, or otherwise
be penalized by a school or landlord solely for the person's status
as a cardholder, unless failing to do so would violate federal law or
regulations or cause the school or landlord to lose a monetary or
licensing-related benefit under federal law or regulation. This
section does not prevent a landlord from imposing reasonable
restrictions on the medical use of cannabis by a cardholder who
resides at the landlord's property.
Section 18. That § 34-20G-20 be REPEALED.
For the purposes of
medical care, including organ and tissue transplants, a registered
qualifying patient's use of cannabis in accordance with this chapter
is considered the equivalent of the authorized use of any other
medication used at the discretion of a practitioner and does not
constitute the use of an illicit substance or otherwise disqualify a
qualifying patient from needed medical care.
Section 19. That § 34-20G-21 be REPEALED.
No person may be denied
custody of, visitation rights with, or parenting time with a minor
solely because the person is a cardholder. There is no presumption of
neglect or child endangerment for conduct allowed under this chapter,
unless the person's behavior creates an unreasonable danger to the
safety of the minor. Nothing in this chapter supersedes or otherwise
affects custody decisions, visitation rights, or parenting time based
upon the best interests of the child.
Section 20. That § 34-20G-22 be REPEALED.
Except as otherwise
provided in this chapter, a registered qualifying patient who uses
cannabis for a medical purpose must be afforded the same rights under
state and local law, as the person would be afforded if the person
were solely prescribed a pharmaceutical medication, as it pertains
to:
(1) Any interaction with
a person's employer;
(2) Drug testing by a
person's employer; or
(3) Drug testing required
by any state or local law, agency, or government official.
Nothing in this section
prohibits adverse employment action, based solely on a positive test
result for cannabis metabolites, if the person is employed in a
safety-sensitive job.
Nothing in this section
prohibits an employer from refusing to hire a person, based solely on
a positive test result for cannabis metabolites, if the person is
seeking employment in a safety-sensitive job.
Section 21. That § 34-20G-23 be REPEALED.
The rights provided by
§§ 34-20G-19
to 34-20G-25,
inclusive, do not apply to the extent that they conflict with an
employer's obligations under federal law or regulation or to the
extent that they would disqualify an employer from a monetary or
licensing-related benefit under federal law or regulation.
Section 22. That § 34-20G-24 be REPEALED.
No employer is required
to allow the ingestion, possession, transfer, display, or
transportation of cannabis in any workplace or to allow any employee
to work while under the influence of cannabis.
No employer is prohibited
from establishing and enforcing a drug-free workplace policy, which
may include a drug testing program that complies with state and
federal law, or acting with respect to an applicant or employee under
the policy.
No cause of action is
created for employment discrimination or wrongful termination arising
from an employer's enforcement of a drug-free workplace policy in
compliance with this chapter.
Section 23. That § 34-20G-25 be REPEALED.
No school, landlord, or
employer may be penalized or denied any benefit under state law for
enrolling, leasing to, or employing a cardholder.
Section 24. That § 34-20G-25.1 be REPEALED.
A health care facility,
as defined in § 34-12-1.1,
an accredited prevention or treatment facility, as defined in
§ 34-20A-2,
a mental health center, as defined in § 27A-1-1,
a child welfare agency, as defined in § 26-6-1,
or a community support provider or community services provider, as
defined in § 27B-1-17,
may adopt restrictions on the use of medical cannabis by a cardholder
who resides at, is actively receiving treatment or care from, or is
visiting the facility. The restrictions may include a provision that
the facility will not store or maintain the cardholder's supply of
medical cannabis, that the facility is not responsible for providing
the medical cannabis for cardholders, and that the medical cannabis
be used only in a place specified by the facility. Nothing in this
section requires a facility to adopt such restrictions or requires a
facility to allow the consumption of medical cannabis on the grounds
of the facility.
No employee or agent of a
facility may be subject to arrest, prosecution, or penalty of any
kind, or may be denied any right or privilege, including any civil
penalty or disciplinary action by a court or occupational or
professional licensing board for possession of medical cannabis while
carrying out employment duties, including providing or supervising
care to a cardholder, or distribution of medical cannabis to a
cardholder who resides at or is actively receiving treatment or care
at the facility with which the employee or agent is affiliated.
Section 25. That § 34-20G-27 be REPEALED.
Nothing in this chapter
requires:
(1) A government medical
assistance program or private health insurer, workers' compensation
insurance carrier, or self-insured employer providing workers'
compensation benefits, to reimburse a person for costs associated
with the medical use of cannabis;
(2) Any person or
establishment in lawful possession of property to allow a guest,
client, customer, or other visitor to smoke or vape cannabis on or in
that property;
(3) A landlord to allow
the cultivation of cannabis on the rental property; or
(4) A state or local
government to allow any conduct otherwise permitted by this chapter
within a building owned, leased, or occupied by the state or local
government.
Section 26. That § 34-20G-28 be REPEALED.
Nothing in this chapter
prohibits an employer from disciplining an employee for ingesting
cannabis in the workplace or for working while under the influence of
cannabis.
Section 27. That § 34-20G-28.1 be REPEALED.
Each application for a
registry identification card and each application for a card renewal
must include a notice that:
(1) The Gun Control Act
of 1968, 18 U.S.C. § 922 (January 1, 2024), prohibits any
person who is an unlawful user of or addicted to any controlled
substance, as defined by the Controlled Substances Act of 1970, 21
U.S.C. § 801, et seq., (January 1, 2024), from shipping,
transporting, receiving, or possessing a firearm or ammunition;
(2) Until marijuana is
legalized under federal law, an individual who is a current user of
marijuana is, under federal law, an unlawful user of a controlled
substance; and
(3) Federal law does not
exempt the use of marijuana for medicinal purposes.
Section 28. That § 34-20G-29 be REPEALED.
The department shall
issue a registry identification card to a qualifying patient who
submits the following, in accordance with rules promulgated by the
department:
(1) A written
certification issued by a practitioner within ninety days immediately
preceding the date of an application;
(2) The application or
renewal fee;
(3) The name, address,
and date of birth of the qualifying patient, except that if the
applicant is homeless, no address is required;
(4) The name, address,
and telephone number of the qualifying patient's practitioner;
(5) The name, address,
and date of birth of the designated caregiver, or designated
caregivers, chosen by the qualifying patient;
(6) If more than one
designated caregiver is designated at any given time, documentation
demonstrating that a greater number of designated caregivers are
needed due to the patient's age or medical condition;
(7) The name of no more
than two dispensaries that the qualifying patient designates, if any;
and
(8) If the qualifying
patient designates a designated caregiver, a designation as to
whether the qualifying patient or designated caregiver will be
allowed under state law to possess and cultivate cannabis plants for
the qualifying patient's medical use.
When a practitioner
conducts a follow-up assessment with a patient, within sixty days of
issuing the patient a written certification, and the purpose of the
follow-up assessment is to assess the patient's response to the use
of medical cannabis and to determine whether to issue the patient a
second written certification, the fee required under subdivision (2)
is waived, if the patient reapplies for the second registry
identification card. A patient may only receive one fee waiver under
this section per calendar year.
Section 29. That § 34-20G-30 be REPEALED.
If the qualifying patient
is unable to submit the information required by § 34-20G-29
due to the person's age or medical condition, the person responsible
for making medical decisions for the qualifying patient may do so on
behalf of the qualifying patient.
Section 30. That § 34-20G-31 be REPEALED.
Except as provided in
§ 34-20G-32,
the department shall:
(1) Verify the
information contained in an application or renewal submitted pursuant
to this chapter and approve or deny an application or renewal within
fifteen days of receiving a completed application or renewal
application;
(2) Issue registry
identification cards to a qualifying patient and to a qualifying
patient's designated caregivers, if any, within five days of
approving the application or renewal. A designated caregiver shall
have a registry identification card for each of the qualifying
patients; and
(3) Enter the registry
identification number of any dispensary the patient designates into
the verification system.
Section 31. That § 34-20G-32 be REPEALED.
The department may
conduct a background check of a designated caregiver in order to
carry out the provisions of § 34-20G-31.
Section 32. That § 34-20G-33 be REPEALED.
The department may not
issue a registry identification card to a qualifying patient who is
younger than eighteen years of age unless:
(1) The qualifying
patient's practitioner has explained the potential risks and benefits
of the medical use of cannabis to the custodial parent or legal
guardian with responsibility for health care decisions for the
qualifying patient; and
(2) The custodial parent
or legal guardian with responsibility for health care decisions for
the qualifying patient consents in writing to:
(a) Allow the qualifying
patient's medical use of cannabis;
(b) Serve as the
qualifying patient's designated caregiver; and
(c) Control the
acquisition of the cannabis, the dosage, and the frequency of the
medical use of cannabis by the qualifying patient.
Section 33. That § 34-20G-34 be REPEALED.
The department may deny
an application or renewal of a qualifying patient’s registry
identification card only if the applicant:
(1) Does not provide the
required information, fee, or materials;
(2) Does not meet the
requirement to obtain a registry identification card as defined in
§ 34-20G-1;
(3) Previously had a
registry identification card revoked; or
(4) Provided false
information.
Section 34. That § 34-20G-35 be REPEALED.
The department may deny
an application or renewal for a designated caregiver chosen by a
qualifying patient whose registry identification card was granted
only if:
(l) The designated
caregiver does not meet the requirements of a designated caregiver as
defined in § 34-20G-l;
(2) The applicant does
not provide the information required;
(3) The designated
caregiver previously had a registry identification card revoked; or
(4) The applicant or the
designated caregiver provide false information.
Section 35. That § 34-20G-36 be REPEALED.
The department shall give
written notice to the qualifying patient of the reason for:
(1) Denying a registry
identification card to the qualifying patient or to the qualifying
patient's designated caregiver; or
(2) Revoking the registry
identification card of the qualifying patient or the qualifying
patient's designated caregiver.
Section 36. That § 34-20G-37 be REPEALED.
Denial of an application
or renewal under § 34-20G-34
or 34-20G-35
is considered a final department action, subject to judicial review.
Section 37. That § 34-20G-42 be REPEALED.
A registry identification
card shall contain all of the following:
(1) The name of the
cardholder;
(2) A designation of
whether the cardholder is a qualifying patient or a designated
caregiver;
(3) The date of issuance
and expiration date of the registry identification card;
(4) A random ten-digit
alphanumeric identification number, containing at least four numbers
and at least four letters, that is unique to the cardholder;
(5) If the cardholder is
a designated caregiver, the random identification number of the
qualifying patient the designated caregiver will assist;
(6) A clear indication of
whether the cardholder has been designated to cultivate cannabis
plants for the qualifying patient's medical use;
(7) A photograph of the
cardholder; and
(8) The phone number or
website address where the card can be verified.
Section 38. That § 34-20G-43 be REPEALED.
The registry
identification card of a qualifying patient and designated caregiver,
if any, expires on the date noted by the practitioner in the
qualifying patient's written certification, not to exceed one year
after the date of issue.
Section 39. That § 34-20G-44 be REPEALED.
The department shall
maintain a confidential list of:
(a) The name, address,
phone number, and registry identification card number of each person
to whom the department has issued a registry identification card; and
(b) The name, address,
and phone number of a registered qualifying patient's parent or legal
guardian if the patient is under age eighteen.
The list may not be
combined or linked in any manner with any other list or database, nor
may it be used for any purpose not provided for in this chapter.
Section 40. That § 34-20G-45 be REPEALED.
Within one hundred twenty
days of July 1, 2021, the department shall establish a secure phone
or web-based verification system. The verification system shall allow
law enforcement personnel and medical cannabis establishments to
enter a registry identification number and determine whether the
number corresponds with a current, valid registry identification
card. The system may disclose only:
(1) Whether the
identification card is valid;
(2) The name of the
cardholder;
(3) Whether the
cardholder is a qualifying patient or a designated caregiver;
(4) Whether the
cardholder is permitted to cultivate cannabis plants;
(5) The registry
identification number of any affiliated registered qualifying
patient; and
(6) The registry
identification of the qualifying patient's dispensary or
dispensaries, if any.
Section 41. That § 34-20G-46 be REPEALED.
The following
notifications are required:
(1) A registered
qualifying patient shall notify the department of any change in the
applicant’s name or address, or if the patient ceases to have a
debilitating medical condition, within ten days of the change;
(2) A registered
designated caregiver shall notify the department of any change in the
caregiver’s name or address, or if the caregiver becomes aware
the qualifying patient passed away, within ten days of the change;
(3) Before a registered
qualifying patient changes a designated caregiver, the patient shall
notify the department;
(4) If a registered
qualifying patient changes a preference as to who may cultivate
cannabis for the patient, the patient shall notify the department;
(5) If a cardholder loses
a registry identification card, the cardholder shall notify the
department within ten days of becoming aware the card has been lost;
and
(6) Before a registered
qualifying patient changes a designated dispensary, the patient shall
notify the department.
Section 42. That § 34-20G-47 be REPEALED.
Any notification that a
registered qualifying patient is required to make under this chapter
may be made by the patient's designated caregiver if the qualifying
patient is unable to make the notification due to age or medical
condition.
Section 43. That § 34-20G-48 be REPEALED.
If a cardholder notifies
the department of any item listed in § 34-20G-46,
but remains eligible under this chapter, the department shall issue
the cardholder a new registry identification card with a new random
ten-digit alphanumeric identification number within ten days of
receiving the updated information and a twenty dollar fee. If the
person notifying the department is a registered qualifying patient,
the department shall also issue the patient's registered designated
caregiver, if any, a new registry identification card within ten days
of receiving the updated information.
Section 44. That § 34-20G-49 be REPEALED.
A registry identification
card is void if the certifying practitioner notifies the department
in writing that:
(1) The registered
qualifying patient has ceased to suffer from a debilitating medical
condition; or
(2) The practitioner no
longer believes the patient would receive therapeutic or palliative
benefit from the medical use of cannabis.
The registered qualifying
patient has fifteen days to dispose of any cannabis in the registered
qualifying patient's possession.
Section 45. That § 34-20G-50 be REPEALED.
A medical cannabis
establishment shall notify the department within one business day of
any theft or significant loss of cannabis.
Section 46. That § 34-20G-51 be REPEALED.
Except as provided in
§ 34-20G-18
and this section, a person may assert the medical purpose for using
cannabis as a defense to any prosecution involving cannabis, and such
defense is presumed valid where the evidence shows that:
(1) A practitioner has
stated that, in the practitioner's professional opinion, after having
completed a full assessment of the person's medical history and
current medical condition made in the course of a bona fide
practitioner-patient relationship, the patient has a debilitating
medical condition and the potential benefits of using cannabis for
medical purposes would likely outweigh the health risks for the
person;
(2) The person was in
possession of no more than three ounces of cannabis, the amount of
cannabis products allowed by department rules, two flowering
cannabis plants, two cannabis plants that are not flowering, and the
cannabis produced by those plants;
(3) The person was
engaged in the acquisition, possession, use, manufacture,
cultivation, or transportation of cannabis, paraphernalia, or both,
relating to the administration of cannabis to treat or alleviate the
person's debilitating medical condition or symptoms associated with
the person's debilitating medical condition; and
(4) Any cultivation of
cannabis and storage of more than three ounces of cannabis occurred
in a secure location that only the person asserting the defense could
access.
Section 47. That § 34-20G-52 be REPEALED.
An affirmative defense
and motion to dismiss shall fail if the prosecution proves that:
(1) The person had a
registry identification card revoked for misconduct; or
(2) The purpose for the
possession or cultivation of cannabis was not solely for palliative
or therapeutic use by the person with a debilitating medical
condition who raised the defense.
Section 48. That § 34-20G-53 be REPEALED.
A person is not required
to possess a registry identification card to raise the affirmative
defense set forth in § 34-20G-51.
Section 49. That § 34-20G-54 be REPEALED.
If a person demonstrates
the person's medical purpose for using cannabis pursuant to this
chapter, except as provided in § 34-20G-18,
the person is not subject to the following for the person's use of
cannabis for medical purposes:
(1) Disciplinary action
by an occupational or professional licensing board or bureau; or
(2) Forfeiture of any
interest in or right to any property other than cannabis.
Section 50. That § 34-20G-55 be REPEALED.
Not later than ninety
days after receiving an application for a medical cannabis
establishment, the department shall register the prospective medical
cannabis establishment and issue a registration certificate and a
random ten-digit alphanumeric identification number if all of the
following conditions are satisfied:
(1) The prospective
medical cannabis establishment has submitted all of the following:
(a) The application fee;
(b) An application,
including:
(i) The legal name of the
prospective medical cannabis establishment;
(ii) The physical address
of the prospective medical cannabis establishment that is not within
one thousand feet of a public or private school existing before the
date of the medical cannabis establishment application;
(iii) The name and date
of birth of each principal officer and board member of the proposed
medical cannabis establishment; and
(iv) Any additional
information requested by the department;
(c) Operating procedures
consistent with rules for oversight of the proposed medical cannabis
establishment, including procedures to ensure accurate record keeping
and adequate security measures;
(d) If the city or county
where the proposed medical cannabis establishment would be located
has enacted zoning restrictions, a sworn statement certifying that
the proposed medical cannabis establishment does not violate the
restrictions;
(e) If the city or county
where the proposed medical cannabis establishment requires a local
registration, license, or permit, a copy of the registration,
license, or permit;
(2) None of the principal
officers or board members has served as a principal officer or board
member for a medical cannabis establishment that has had its
registration certificate revoked;
(3) None of the principal
officers or board members is under twenty-one years of age; and
(4) At least one
principal officer is a resident of this state.
Section 51. That § 34-20G-56 be REPEALED.
If the governing body of
a county has enacted a numerical limit on the number of medical
cannabis establishments in the county and a greater number of
applicants seek registration, the department shall solicit and
consider input from the county as to its preference for registration.
If the governing body of
a municipality has enacted a numerical limit on the number of medical
cannabis establishments in the municipality, and a greater number of
applicants seek registration, the department shall solicit and
consider input from the municipality as to its preference for
registration.
Section 52. That § 34-20G-57 be REPEALED.
The department shall
issue a renewal registration certificate within forty-five days of
receipt of the prescribed renewal application and renewal fee from a
medical cannabis establishment.
Section 53. That § 34-20G-58 be REPEALED.
The governing body of a
municipality may enact an ordinance not in conflict with this
chapter, regardless of whether it has enacted a zoning ordinance
pursuant to title 11, imposing:
(1) Restrictions on a
medical cannabis establishment to govern the time, place, and manner
of operation;
(2) A limit on the number
of medical cannabis establishments in the municipality;
(3) Reasonable setback
requirements;
(4) Limitations on the
proximity of a medical cannabis establishment to:
(a) Any sensitive
land-use area, including a childcare facility, park, public service
facility, recreational facility, religious facility, school, and any
location frequented by individuals under the age of twenty-one; or
(b) Any other medical
cannabis establishment;
(5) Requirements for a
medical cannabis establishment to obtain a local license, permit, or
registration to operate; or
(6) Reasonable fees for
any local license, permit, or registration.
The governing body of a
county may enact an ordinance governing all matters set forth in this
section. The county ordinance applies throughout its jurisdiction,
except within the boundaries of a municipality that has enacted an
ordinance in accordance with this section.
A county or municipality
may impose a civil penalty for the violation of an ordinance enacted
in accordance with this section.
Section 54. That § 34-20G-59 be REPEALED.
No county or municipality
may prohibit a dispensary, either expressly or through the enactment
of an ordinance that makes the operation of the dispensary
impracticable in the county or municipality.
Section 55. That § 34-20G-61 be REPEALED.
Each medical cannabis
establishment shall conduct a background check into the criminal
history of each person seeking to become a principal officer, board
member, agent, volunteer, or employee before the person begins
working at the medical cannabis establishment.
Section 56. That § 34-20G-62 be REPEALED.
A medical cannabis
establishment may not employ any person who:
(1) Was convicted of a
disqualifying felony offense; or
(2) Is under twenty-one
years of age.
Section 57. That § 34-20G-63 be REPEALED.
Each medical cannabis
establishment shall have operating documents that include procedures
for the oversight of the medical cannabis establishment and
procedures to ensure accurate record keeping.
Section 58. That § 34-20G-64 be REPEALED.
A medical cannabis
establishment shall implement appropriate security measures designed
to deter and prevent the theft of cannabis and unauthorized entrance
into any area containing cannabis.
Section 59. That § 34-20G-65 be REPEALED.
All cultivation,
harvesting, manufacturing and packaging of cannabis shall take place
in a secure facility at a physical address provided to the department
during the registration process. The secure facility may only be
accessed by agents of the medical cannabis establishment, emergency
personnel, and adults who are twenty-one years of age and older and
who are accompanied by a medical cannabis establishment agent.
Section 60. That § 34-20G-65.1 be REPEALED.
A sample of cannabis or
cannabis products submitted to a testing facility must be collected
by a designated representative of the testing facility.
A medical cannabis
establishment shall ensure that testing is conducted on a sample of
cannabis or cannabis product immediately prior to the transfer of the
cannabis for retail sale or cannabis product in final form to another
medical cannabis establishment.
Section 61. That § 34-20G-66 be REPEALED.
No medical cannabis
establishment other than a cannabis product manufacturer may produce
cannabis concentrates, cannabis extractions, or other cannabis
products.
Section 62. That § 34-20G-67 be REPEALED.
A medical cannabis
establishment may not share office space with or refer a patient to a
practitioner.
Section 63. That § 34-20G-68 be REPEALED.
A medical cannabis
establishment may not permit any person to consume cannabis on the
property of a medical cannabis establishment.
Section 64. That § 34-20G-69 be REPEALED.
A medical cannabis
establishment is subject to inspection by the department during
business hours.
Section 65. That § 34-20G-70 be REPEALED.
A dispensary may not
dispense more than three ounces of cannabis or a cannabis product to
a registered qualifying patient or a nonresident cardholder, directly
or via a designated caregiver, in any fourteen-day period.
Before cannabis or a
cannabis product may be dispensed to a cardholder or nonresident
cardholder, a dispensary agent must verify:
(1) That the registry
identification card or registration presented to the dispensary is
valid;
(2) The identity of the
person by requiring the person to present a valid photographic
identification document issued by this state, another state, tribe,
or the federal government; and
(3) Through the
department's inventory tracking system, that the registered
qualifying patient or nonresident cardholder has not exceeded the
allowable limit of cannabis or cannabis product in the applicable
fourteen-day period.
A dispensary agent may
not dispense an amount of cannabis or cannabis product to a person
that would cause the person to possess more than the allowable amount
of cannabis.
Section 66. That § 34-20G-71 be REPEALED.
A dispensary shall
maintain internal, confidential records specifying how much cannabis
is dispensed to a nonresident cardholder or registered qualifying
patient and whether it is dispensed directly to a registered
qualifying patient or to the designated caregiver.
Section 67. That § 34-20G-72 be REPEALED.
The department shall
promulgate rules pursuant to chapter 1-26:
(1) Establishing the form
and content of registration and renewal applications submitted under
this chapter and include the notice requirements set forth in
§ 34-20G-28.1;
(2) Establishing a system
to numerically score competing medical cannabis establishment
applicants, in cases where more applicants apply than are allowed by
the local government, that includes analysis of:
(a) The preference of the
local government;
(b) In the case of
dispensaries, the suitability of the proposed location and its
accessibility for patients;
(c) The character,
veracity, background, qualifications, and relevant experience of
principal officers and board members; and
(d) The business plan
proposed by the applicant, that in the case of a cultivation facility
or dispensary shall include the ability to maintain an adequate
supply of cannabis, plans to ensure safety and security of patrons
and the community, procedures to be used to prevent diversion, and
any plan for making cannabis available to low-income registered
qualifying patients;
(3) Governing the manner
in which the department shall consider applications for and renewals
of registry identification cards, that may include creating a
standardized written certification form;
(4) Governing medical
cannabis establishments to ensure the health and safety of qualifying
patients and prevent diversion and theft without imposing an undue
burden or compromising the confidentiality of a cardholder,
including:
(a) Oversight
requirements;
(b) Record-keeping
requirements;
(c) Security
requirements, including lighting, physical security, and alarm
requirements;
(d) Health and safety
regulations, including restrictions on the use of pesticides that are
injurious to human health;
(e) Standards for the
manufacture of cannabis products and both the indoor and outdoor
cultivation of cannabis by a cultivation facility;
(f) Requirements for the
transportation and storage of cannabis by a medical cannabis
establishment;
(g) Employment and
training requirements, including requiring that each medical cannabis
establishment create an identification badge for each agent;
(h) Standards for the
safe manufacture of cannabis products, including extracts and
concentrates;
(i) Restrictions on the
advertising, signage, and display of medical cannabis, provided that
the restrictions may not prevent appropriate signs on the property of
a dispensary, listings in business directories including phone books,
listings in marijuana-related or medical publications, or the
sponsorship of health or not-for-profit charity or advocacy events;
(j) Requirements and
procedures for the safe and accurate packaging, labeling,
distribution, and tracking of medical cannabis;
(k) Certification
standards for testing facilities, including requirements for
equipment and qualifications for personnel; and
(l) Requirements for
samples of cannabis and cannabis products submitted to testing
facilities, including batch sizes to not exceed fifty pounds of
cannabis intended for retail sale, batch sizes for homogenous
cannabis products intended for retail sale, and procedures to ensure
representative sampling;
(5) Establishing
procedures for the suspension and termination of the registry
identification cards of cardholders who commit multiple or serious
violations of this chapter;
(6) Establishing
procedures for:
(a) The imposition of
fines, not to exceed ten thousand dollars per inspection, on a
medical cannabis establishment that is found to have committed
multiple or serious violations of this chapter; and
(b) The probation,
suspension, and termination of the registration certificate of a
medical cannabis establishment that commits multiple or serious
violations of this chapter;
(7) Establishing labeling
requirements for cannabis and cannabis products, including requiring
cannabis product labels to include the following:
(a) The length of time it
typically takes for a product to take effect;
(b) Disclosing
ingredients and possible allergens;
(c) A nutritional fact
panel; and
(d) Requiring that edible
cannabis products be clearly identifiable, when practicable, with a
standard symbol indicating that it contains cannabis;
(8) Establishing
procedures for the registration of nonresident cardholders and the
cardholder's designation of no more than two dispensaries, which
shall require the submission of:
(a) A practitioner's
statement confirming that the patient has a debilitating medical
condition; and
(b) Documentation
demonstrating that the nonresident cardholder is allowed to possess
cannabis or cannabis preparations in the jurisdiction where the
nonresident cardholder resides;
(9) Establishing the
amount of cannabis products, including the amount of concentrated
cannabis, each cardholder and nonresident cardholder may possess; and
(10) Establishing
application and renewal fees for registration certificates, not to
exceed twenty thousand dollars, with this upper limit adjusted
annually for inflation, with the total fees collected sufficient to
offset all costs related to program implementation and
administration; and
(11) Establishing
application and renewal fees for registry identification cards and
nonresident cardholder registration as follows:
(a) Using a sliding scale
of patient application and renewal fees based upon a qualifying
patient's household income;
(b) The fees charged to
qualifying patients, nonresident cardholders, and caregivers may not
be greater than the costs of processing the application and issuing a
registry identification card or registration; and
(c) The department may
accept donations from private sources to reduce application and
renewal fees.
A violation of a required
or prohibited action under any rule authorized by this section is a
Class 2 misdemeanor.
Section 68. That § 34-20G-73 be REPEALED.
A cardholder or medical
cannabis establishment who fails to provide a notice required by this
chapter is subject to a civil penalty of no more than one hundred
fifty dollars. Any civil penalty collected shall be deposited in the
state general fund.
Section 69. That § 34-20G-74 be REPEALED.
In addition to any other
penalty under law, a medical cannabis establishment or an agent of a
medical cannabis establishment who intentionally sells or otherwise
transfers cannabis in exchange for anything of value to a person
other than a cardholder, a nonresident cardholder, or to a medical
cannabis establishment or its agent is guilty of a Class 6 felony. A
person convicted under this section may not continue to be affiliated
with the medical cannabis establishment and is disqualified from any
future affiliation with any medical cannabis establishment under this
chapter.
Section 70. That § 34-20G-75 be REPEALED.
In addition to any other
penalty under law, a cardholder or nonresident cardholder who
intentionally sells or otherwise transfers cannabis in exchange for
anything of value to a person other than a cardholder, a nonresident
cardholder, or to a medical cannabis establishment or its agent is
guilty of a Class 6 felony.
Section 71. That § 34-20G-76 be REPEALED.
A person who
intentionally makes a false statement to a law enforcement official
about any fact or circumstance relating to the medical use of
cannabis to avoid arrest or prosecution is guilty of a Class 2
misdemeanor. The penalty is in addition to any other penalty that may
apply for making a false statement or for the possession,
cultivation, or sale of cannabis not protected by this chapter. If a
person convicted of violating this section is a cardholder, the
person is disqualified from being a cardholder under this chapter.
Section 72. That § 34-20G-77 be REPEALED.
A person who knowingly
submits false records or documentation required by the department to
certify a medical cannabis establishment under this chapter is guilty
of Class 6 felony.
Section 73. That § 34-20G-78 be REPEALED.
A practitioner is guilty
of a Class 2 misdemeanor if the practitioner:
(1) Knowingly refers a
patient to a medical cannabis establishment or to a designated
caregiver in exchange for financial consideration;
(2) Advertises in a
medical cannabis establishment;
(3) Issues written
certifications while holding a financial interest in a medical
cannabis establishment;
(4) Offers a discount,
deal, or other financial incentive for making an appointment with the
practitioner for the purpose of receiving a written certification;
(5) Conducts the medical
assessment required for a bona fide practitioner-patient relationship
in a space licensed for the sale of alcoholic beverages; or
(6) Charges a patient
based on the term of a written certification issued to the patient.
Section 74. That § 34-20G-78.1 be REPEALED.
An entity is guilty of a
Class 2 misdemeanor if the entity:
(1) Offers a discount,
deal, or other financial incentive for making an appointment with a
practitioner for the purpose of receiving a written certification; or
(2) Charges a
practitioner's patient based on the duration of a written
certification issued to the patient.
Section 75. That § 34-20G-78.2 be REPEALED.
If a practitioner or an
immediate family member of the practitioner has a financial
relationship with a medical cannabis clinic, the practitioner may not
knowingly refer a patient to that clinic for the purpose of receiving
a written certification under this chapter.
For purposes of this
section, a "financial relationship" means an ownership or
investment interest in the medical cannabis clinic, or a compensation
arrangement between the practitioner or the practitioner's immediate
family member and the clinic.
An ownership or
investment interest may be through equity, debt, or other means and
includes an interest in an entity that holds an ownership or
investment interest in the medical cannabis clinic.
The prohibition of this
section does not apply:
(1) If the services
offered at the medical cannabis clinic are being provided by another
practitioner in the same group practice as the referring
practitioner;
(2) To a compensation
arrangement, between the practitioner or the practitioner's immediate
family member and the medical cannabis clinic, consisting of payments
under the terms of a written lease that:
(a) Is signed by all the
parties;
(b) Specifies the
premises covered by the lease, provided the premises do not exceed
the space that is reasonable and necessary for the legitimate
business purposes of the lease and further provided that the
premises, aside from common areas, are used exclusively by the
lessee;
(c) Has a duration of at
least twelve months; and
(d) Specifies the rental
charges over the term of the lease, provided the charges are
consistent with fair market value, and are not determined in a manner
that takes into account the volume or value of any referrals or other
business generated between the parties;
(3) To a bona fide
employment relationship under which an immediate family member of the
practitioner is employed by the clinic for identifiable services, and
receives remuneration for those services in an amount that:
(a) Is consistent with
the fair market value of the services; and
(b) Is not determined in
a manner that takes into account, directly or indirectly, the volume
or value of any referrals by the referring practitioner; and
(4) To an isolated
transaction, such as a one-time sale of property.
Any practitioner who
knowingly refers a patient to a medical cannabis clinic, with which
the practitioner or an immediate family member of the practitioner
has a financial relationship, is guilty of a Class 2 misdemeanor.
Section 76. That § 34-20G-79 be REPEALED.
It is a Class 2
misdemeanor for any person, including an employee or official of the
department or another state agency or local government, to breach the
confidentiality of information obtained under this chapter.
Section 77. That § 34-20G-80 be REPEALED.
The department may, after
notice and hearing in accordance with chapter 1-26,
impose probation, impose a fine, suspend, or revoke a registration
certificate for multiple negligent or knowing violations of this
chapter, or for a serious and knowing violation of this chapter, by
the registrant or any of its agents.
The department may not:
(1) Impose a probation
period that exceeds six months; or
(2) Suspend a
registration certificate for a period that exceeds six months, except
for a serious violation of patient health and safety, in which case
the suspension may not exceed one year.
Section 78. That § 34-20G-81 be REPEALED.
The department shall
provide notice of probation, fine, suspension, or revocation by
mailing the same in writing to the medical cannabis establishment at
the address on the registration certificate.
Section 79. That § 34-20G-82 be REPEALED.
A medical cannabis
establishment may continue to possess cannabis during a suspension,
but it may not dispense, transfer, or sell cannabis. A cultivation
facility may continue to cultivate and possess cannabis plants during
a suspension, but it may not dispense, transfer, or sell cannabis.
Section 80. That § 34-20G-83 be REPEALED.
The department shall
immediately revoke the registry identification card of any cardholder
who sells cannabis to a person who is not allowed to possess cannabis
for medical purposes under this chapter, and the cardholder is
disqualified from being a cardholder under this chapter.
Section 81. That § 34-20G-84 be REPEALED.
The department may revoke
the registry identification card of any cardholder who knowingly
commits multiple unintentional violations or a serious knowing
violation of this chapter.
Section 82. That § 34-20G-85 be REPEALED.
Revocation under
§ 34-20G-80,
34-20G-83,
or 34-20G-84
is a final decision of the department subject to judicial review.
Section 83. That § 34-20G-86 be REPEALED.
Data in a registration
application and supporting data submitted by a qualifying patient,
designated caregiver, nonresident cardholder, or medical cannabis
establishment, including data on designated caregiver or
practitioner, is not a public record open to public access,
inspection, or copying under chapter 1-27.
All other public records concerning registered medical cannabis
establishments are governed by chapter 1-27.
Section 84. That § 34-20G-87 be REPEALED.
Except as provided in
§ 34-20E-2,
data kept or maintained by the department may not be used for any
purpose not provided for in this chapter and may not be combined or
linked in any manner with any other list or database.
Section 85. That § 34-20G-88 be REPEALED.
Confidential data or data
that is not a public record kept or maintained by the department may
only be disclosed as necessary to:
(1) Verify a registration
certificate or registry identification card pursuant to this chapter;
(2) Notify law
enforcement of an apparent criminal violation of this chapter or
respond to law enforcement or prosecutorial officials engaged in the
investigation or enforcement of the criminal provisions of this
chapter;
(3) Notify state and
local law enforcement about falsified or fraudulent information
submitted for the purpose of obtaining or renewing a registry
identification card;
(4) Notify the applicable
licensing board if there is reason to believe that a practitioner has
violated the standard of care for evaluating a medical condition; or
respond to the board, if the board is seeking data relevant to an
investigation of a person who holds a license issued by the board;
(5) Any judicial
authority under grand jury subpoena or court order or equivalent
judicial process for investigation of criminal, civil, or
administrative violations related to the use of medical cannabis;
(6) An authorized
employee of the department performing official duties associated with
the medical cannabis program;
(7) A practitioner to
determine if a person in the practitioner's care engages in the
medical use of cannabis so the practitioner may assess possible drug
interactions or assess other medically necessary concerns; or
(8) Comply with the
reporting requirement in § 34-20G-88.1.
Section 86. That § 34-20G-88.1 be REPEALED.
The department shall
submit the name and date of birth of a qualifying patient who
receives a registry identification card to the prescription drug
monitoring program authorized pursuant to chapter 34-20E.
Section 87. That § 34-20G-89 be REPEALED.
Except as otherwise
provided in this section, information kept or maintained by a medical
cannabis establishment may identify a cardholder only by registry
identification number and may not contain names or other personally
identifiable information.
A cardholder may, in
writing, authorize an establishment to maintain the cardholder's name
and other personally identifiable information, for the limited
purpose of receiving direct communication regarding the cardholder's:
(1) Individual medical
needs; or
(2) Use of a specific
product.
Section 88. That § 34-20G-90 be REPEALED.
At the cardholder's
request, the department may confirm the cardholder's status as a
registered qualifying patient or a registered designated caregiver to
a third party, such as a landlord, school, medical professional, or
court.
Section 89. That § 34-20G-91 be REPEALED.
Any department hard drive
or other data-recording media that is no longer in use and that
contains cardholder information shall be destroyed.
Section 90. That § 34-20G-92 be REPEALED.
The Executive Board of
the Legislative Research Council shall appoint an oversight committee
consisting of:
(1) Two members of the
Senate;
(2) Two members of the
House of Representatives;
(3) One physician
licensed in accordance with chapter 36-4;
(4) One physician
assistant licensed in accordance with chapter 36-4A;
(5) One certified nurse
practitioner licensed in accordance with chapter 36-9A;
(6) One chief of police
for a municipality having a population in excess of fifty-thousand,
or a representative of the police department designated by the chief;
(7) One sheriff of a
county or a representative of the sheriff's office designated by the
sheriff;
(8) One professional
counselor licensed in accordance with chapter 36-32
or one addiction counselor licensed in accordance with chapter 36-34;
and
(9) One qualifying
patient.
Each appointee shall
serve for a term of two years and may be reappointed.
Section 91. That § 34-20G-92.1 be REPEALED.
Beginning in 2023, and
every two years thereafter, the oversight committee shall select from
among itself one legislator to serve as the chair and one legislator,
from the opposite chamber, to serve as the vice chair.
Beginning in 2025, the
legislators selected to serve as the chair and vice chair may not be
from the same chamber as their immediate predecessors.
Section 92. That § 34-20G-93 be REPEALED.
The oversight committee
shall meet at least two times per year for the purpose of evaluating
and making recommendations to the Legislature and the department
regarding:
(1) The ability of
qualifying patients in all areas of the state to obtain timely access
to high-quality medical cannabis;
(2) The effectiveness of
the dispensaries and cultivation facilities, individually and
together, in serving the needs of qualifying patients, including the
provision of educational and support services by dispensaries, the
reasonableness of their prices, whether they are generating any
complaints or security problems, and the sufficiency of the number
operating to serve the state's registered qualifying patients;
(3) The effectiveness of
the cannabis testing facilities, including whether a sufficient
number are operating;
(4) The sufficiency of
the regulatory and security safeguards contained in this chapter and
adopted by the department to ensure that access to and use of
cannabis cultivated is provided only to cardholders;
(5) Any recommended
additions or revisions to the department regulations or this chapter,
including recommendations relating to security, safe handling,
labeling, and nomenclature;
(6) Any research studies
regarding health effects of medical cannabis for patients; and
(7) Any medical and
clinical aspects of the medical cannabis program.
The oversight committee
shall ensure that it seeks relevant input from qualifying patients;
designated caregivers; pharmacists; school boards and administrators;
parents; municipal representatives; state agencies, including the
Department of Health, the South Dakota Division of Criminal
Investigation, and the Department of Public Safety; and medical
cannabis establishments.
Section 93. That § 34-20G-94 be REPEALED.
The department shall
report annually to the Legislature on the number of applications for
registry identification cards received; the number of qualifying
patients and designated caregivers approved; the number of registry
identification cards revoked; the number of each type of medical
cannabis establishment registered; the expenses incurred and revenues
generated from the medical cannabis program; the number of patient
cardholders by medical condition; qualifying patient demographics by
age and sex; the number and specialty of the practitioners providing
written certifications; the number of medical cannabis establishments
by type; the number of licensing violations determined by the
department; the impact of medical cannabis on public safety, public
health, and behavioral health services; any other information
regarding the effects of medical cannabis on the public; and any
recommendations. The department may not include identifying
information on a qualifying patient, designated caregiver, or
practitioner in the report.
Section 94. That § 34-20G-95 be REPEALED.
The Department of
Education and the department shall establish policy to allow students
who are medical cannabis cardholders to have their medicine
administered in school in accordance with their physician's
recommendation. This policy shall be implemented the first day of the
new school year following passage of this chapter. The departments
shall implement substantively identical provisions to Colorado
Revised Statute 22-1-119.3 as of January 1, 2019.
Section 95. That § 34-20G-96 be REPEALED.
In order for an
individual who is serving a probationary sentence under the
supervision of the Unified Judicial System or who is on conditional
release or parole from a state correctional facility under the legal
custody of the Department of Corrections to utilize medical cannabis,
the individual's practitioner must attest that the use of medical
cannabis is:
(1) Consistent with the
medical standard of care for the treatment of the individual’s
documented debilitating medical condition and any symptoms associated
with the debilitating medical condition;
(2) Reasonable in light
of the practitioner’s observation and the individual's physical
examination, diagnostic test results, medical history, and reported
symptoms; and
(3) Reasonable in light
of the risks and benefits of medical cannabis as compared to the
risks and benefits of other treatment options for the individual’s
debilitating medical condition and any symptoms associated with the
debilitating medical condition.
Underscores indicate new language.
Overstrikes
indicate deleted language.